Saudi Speaks On The Criticism His Debut Album ‘Drugs Inc.’ Received & How AE Failed At Promoting It

Saudi Speaks On The Criticism His Debut Album ‘Drugs Inc.’ Received & How AE Failed At Promoting It. Saudi has opened up a little more about his experiences in regards to his debut album Drugs Inc.

The Abangani rapper dropped the debut album Drugs Inc baxk in 2017. Unfortunately, it wasn’t initially received too well through the judgment of how it promotes the use of drugs.

The criticism was rooted on the title, it was when people heard the songs in it that they withdrew their criticism. Saudi even clarified on what Drugs Inc. actually stand for.

“When I titled the album Drugs Inc, I got a lot of flak from some in my inner circle, not from Sjava or Ruff. It’s an acronym, Devil’s Revenge Upon God’s Servants Is Not Crime, and some didn’t understand that. They thought I was promoting something I wasn’t.”

When the album finally reached a point of success, Saudi became bold enough to say that critics were wrong and he was right.

“When I finally did it, and it came full circle and got the kind of cosigns I got at the end of it, it was proved that I was right and those who were criticising my album were wrong.”
He added on to reveal how he experienced difficulties with promoting the album, saying Ambitiouz Entertainment could have done more.

“The album was appreciated, but I didn’t feel like it was promoted enough. But that is a lesson learnt and water under the bridge.”

At this point Saudi is focused on other porhevts including his newly sealed deal with Bacardi for their new “Sound of Rum” campaign.